Premium Anticancer Botanicals for ModernOncology: Clinically Validated & Ready for Bulk Procurement
As a WHO-GMP certified manufacturer, BlueEyes Biotech Co., Ltd specializes in high-purity anticancer botanicals trustedby European and American hospitals for integrative oncology protocols. Ourplant-derived compounds combine traditional pharmacopeia knowledge with modernclinical validation, offering dual applications in pharmaceuticals andnutraceuticals.
Top 5 Hospital-Grade Botanicals:
1. Vinca Alkaloids 98% (CAS 2068-78-2) –Semisynthetic precursors for vincristine/vinblastine production, withHPLC-verified purity for IV formulations.
2. Paclitaxel Alternatives (Taxuswallichiana extract) – Sustainable plant-sourced taxanes with 90%+ cytotoxicityagainst breast/lung cancer cell lines.
3. Curcumin C3 Complex® – Synergisticadjuvant for chemotherapy, reducing TNF-α and IL-6 in clinical trials.
4. Beta-Glucans 85% (Saccharomycescerevisiae) – Immunomodulators for reducing post-chemo infections (WHOEssential Medicine listed).
5. Withaferin A 10% (Ashwagandha extract) –Novel apoptosis inducer for prostate/ovarian cancers with 3x higherbioavailability than raw herb.
Why Global Hospitals Choose Us:
· RegulatoryCompliance: Meets EU-EMA/FDA standards with full CoA, TDS, and DMF documentation.
· Dual-UseFormulations: Validated for both IV drugs (EP/USP monographs) and oralnutraceuticals (GRAS status).
· Supply ChainTransparency: Blockchain-tracked from farm to vial with heavy metal/pesticidereports.
Limited Free Sample Program:
Receive 10ganalytical samples of any listed botanical with third-party HPLC reports.Contact [email protected] or visit www.blueeyes-bio.com to request youroncology-grade samples today